Zolmitriptan clinical trials
Also written Zomig.
How each study uses zolmitriptan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 25 Nov 1997 · ZOMIG · NDA 020768 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
9 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 3
AstraZeneca (3) · Acorda Therapeutics (2) · Impax Laboratories, LLC (1) · Pamukkale University (1) · California Medical Clinic for Headache (1) · Xijing Hospital (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses zolmitriptan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in AdolescentsCompletedPhase 3Impax Laboratories, LLCNCT00617695Written as Zolmitriptan
- A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation PowderCompletedPhase 1Acorda TherapeuticsNCT02905227Written as CVT-427 (zolmitriptan inhalation powder)
- Efficacy and Safety of Zolmitriptan by Sublingual AdministrationStatus unknownPhase 4Xijing HospitalNCT03377257Written as zolmitriptan by sublingual administration
- Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine in Emergency DepartmentCompletedPhase 4Pamukkale UniversityNCT03145467Written as Zolmitriptan
- Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy AdultsCompletedPhase 1Acorda TherapeuticsNCT02609945Written as zolmitriptan
- Zomig - Treatment of Acute Migraine Headache in AdolescentsCompletedPhase 4AstraZenecaNCT01211145Written as Zolmitriptan
- Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of MigraineCompletedNot applicableCalifornia Medical Clinic for HeadacheNCT01276977Written as Zolmitriptan 5 mg Nasal Spray
- ZAP, US. Zomig for Appropriate for Primary CareCompletedPhase 4AstraZenecaNCT00637286Written as Zolmitriptan
- Efficacy and Tolerability of Zolmitriptan Nasal SprayCompletedPhase 3AstraZenecaNCT00617747Written as Zolmitriptan
Given beside what is tested · 5 — zolmitriptan is usual care or a partner of the new treatment
- Cocaine and ZolmitriptanCompletedEarly Phase 1William StoopsNCT05019430Written as Zolmitriptan
- A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy VolunteersCompletedPhase 1Zosano Pharma CorporationNCT03978403Written as Zolmitriptan 2.5 mg/0.1 mL nasal spray [ZOMIG] single dose
- Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy VolunteersCompletedPhase 1Zosano Pharma CorporationNCT04969497Written as Treatment C: 5.0 mg Intranasal Zolmitriptan administered at time = 0 and 2 hours post time 0
- A Study of M207 With Intranasal Zolmitriptan in Healthy VolunteersCompletedPhase 1Zosano Pharma CorporationNCT03708744Written as D:zolmitriptan nasal spray
- Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male VolunteersCompletedPhase 1AstraZenecaNCT01085123Written as Rapimelt
As the comparator · 1 — what is tested is compared with zolmitriptan
Codes
What other systems call zolmitriptan · ClinicalTrials.gg INT003802
- MeSH (NLM) C089750zolmitriptanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2FS66TH3YWZOLMITRIPTANConfirmed FDA, NLM, Wikidata
- RxNorm 135775Confirmed FDA, Wikidata
- Wikidata Q218820zolmitriptanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47789ZolmitriptanOne source FDA
- DrugBank DB00315One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C089750 | zolmitriptan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2FS66TH3YW | ZOLMITRIPTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 135775 | — | Confirmed FDA, Wikidata |
| Wikidata | Q218820 | zolmitriptan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47789 | Zolmitriptan | One source FDA |
| DrugBank | DB00315 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.